Structured evidence table for Resveratrol Blood Glucose Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Resveratrol Blood Glucose Randomized Trial | Obesity, defined as excessive accumulation of adipose tissue, is strongly associated with metabolic complications, including hypertension, dyslipidemia, and type 2 diabetes [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Blood Glucose Randomized Trial | Chronic low-grade inflammation associated with obesity contributes to metabolic dysfunction through the increased production of pro-inflammatory cytokines and adipocytokines []. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Blood Glucose Randomized Trial | 5 6 7 8 9 10 11 Studies show that obesity significantly increases the risk of chronic diseases, including type 2 diabetes, cardiovascular disease, hypertension, dyslipidemia, hyperuricemia, and insulin resistance [,]. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Blood Glucose Randomized Trial | 1 2 3 4 Metabolic disorders pose a serious challenge to healthcare systems worldwide due to their significant impact on quality of life, requiring a holistic approach in the context of prevention, diagnosis, and treatment. | 1 | Gazda Patrycja (2026) | The Role of Anthocyanins, Curcumin, and Resveratrol in the Prevention and Management of Metabolic Disorders: A Systematic Review |
| Resveratrol Blood Glucose Randomized Trial | Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones’ withdrawal []. | 3 | Karaflou Maria (2026) | Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes |
| Resveratrol Blood Glucose Randomized Trial | Body composition changes with increased fat mass and abdominal fat distribution are associated with insulin resistance and subsequent diabetes in older ages [,]. | 3 | Karaflou Maria (2026) | Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes |
| Resveratrol Blood Glucose Randomized Trial | 5 6 7 Oxidative stress is closely associated with conditions that predispose individuals to T2DM, including obesity. | 3 | Karaflou Maria (2026) | Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes |
| Resveratrol Blood Glucose Randomized Trial | 1 1 2 www.pubmed.gov Menopause and male late-onset hypogonadism (LOH) are well-described transitions in females and males during their lifespan. | 3 | Karaflou Maria (2026) | Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes |
Source documents